AI in Drug Discovery: Who is leading the race according to those who will Rx their products?
Learn in this report about transforming drug development with AI (artificial intelligence) and ML (machine learning). And find out who in big pharma are seen as leading the charge in the industry
In this research, conducted with over 200 physicians including over 200 UK and US Oncologists, Neurologists, and Hematologists, we delve into the future developments of these new technologies in drug innovation.
The core questions answered in the report are:
- Expectations of AI: Discovering how physicians perceive AI and ML in drug discovery and its impact on their patients
- AI leaders in pharma: Identifying which companies are recognized as most the leaders in integrating AI and ML into drug discovery.
- Trust in companies: Crucially, which companies are seen as trustworthy to harness these new technologies safely
In this research, conducted with over 200 physicians including over 200 UK and US Oncologists, Neurologists, and Hematologists, we delve into the future developments of these new technologies in drug innovation.
The core questions answered in the report are:
- Expectations of AI: Discovering how physicians perceive AI and ML in drug discovery and its impact on their patients
- AI leaders in pharma: Identifying which companies are recognized as most the leaders in integrating AI and ML into drug discovery.
- Trust in companies: Crucially, which companies are seen as trustworthy to harness these new technologies safely